Shares of SentinelOne, Inc. S rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook.
SentinelOne reported third-quarter revenue of $164.2 million, beating the analyst consensus estimate of $156.09 million. The company also reported an adjusted loss of 3 cents per share, beating the analyst consensus estimate of a loss of 8 cents per share, according to Benzinga Pro.
The company raised the full-year 2024 revenue outlook from $605 million to $616 million.
SentinelOne shares gained 18.6% to $23.71 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Clean Earth Acquisitions Corp. CLIN shares gained 105.5% to $12.64 in pre-market trading after falling over 3% on Tuesday.
- Greenbrook TMS Inc. GBNH shares rose 78.7% to $0.4109 in pre-market trading after the company announced it raised $2.5 million in debt financing.
- Dune Acquisition Corporation DUNE rose 23.8% to $6.08 in pre-market trading after dipping over 15% on Tuesday.
- Bit Brother Limited BETS gained 23.5% to $0.0414 in pre-market trading. Bit Brother shares fell over 51% on Tuesday after the company announced the pricing of a $12 million registered direct offering.
- Aclaris Therapeutics, Inc. ACRS shares rose 19.6% to $1.18 in pre-market trading. Aclaris Therapeutics announced exclusive patent license agreement with Sun Pharma for rights of deuruxolitinib.
- Meiwu Technology Company Limited WNW shares surged 17.1% to $0.0937 in pre-market trading after gaining 11% on Tuesday.
- Phio Pharmaceuticals Corp. PHIO shares rose 17% to $1.31 in pre-market trading.
- Mobiv Acquisition Corp MOBV gained 16.4% to $5.82 in pre-market trading after gaining 5% on Tuesday.
- Aspen Aerogels, Inc. ASPN shares climbed 12.7% to $12.00 in pre-market trading. Aspen Aerogels reported additional EV Thermal barrier commercial award and issued an update on U.S. Department of Energy loan application status.
Losers
- ImmunoPrecise Antibodies Ltd. IPA dipped 28.6% to $1.10 in pre-market trading after reporting a proposed public offering of common shares.
- NeuroSense Therapeutics Ltd. NRSN shares fell 16.7% to $0.94 in pre-market trading after declining 24% on Tuesday. The company announced that it met its primary safety, tolerability and secondary clinical efficacy endpoints in its Phase 2b PARADIGM Trial of PrimeC in ALS.
- Yext, Inc. YEXT shares fell 15.6% to $5.92 in pre-market trading after the company reported third-quarter financial results and issued guidance.
- Allarity Therapeutics, Inc. ALLR shares fell 13.7% to $0.50 in pre-market trading. Allarity recently announced initial results from its ongoing Phase 2 clinical trial evaluating the efficacy of stenoparib in women with advanced ovarian cancer.
- Asana, Inc. ASAN shares fell 13.4% to $20.19 in pre-market trading. Asana posted upbeat results for its third quarter and issued a strong forecast for FY24.
- Box, Inc. BOX fell 13% to $23.22 in pre-market trading after the company reported worse-than-expected third-quarter financial results and issued FY24 guidance below estimates.
- Abits Group Inc. ABTS shares fell 12% to $1.10 in pre-market trading after jumping 19% on Tuesday.
- Nxu, Inc. NXU fell 11.8% to $0.0225 in pre-market trading after declining more than 6% on Tuesday. NXU named Sarah Wyant as interim CFO, succeeding Apoorv Dwivedi.
- Better Choice Company Inc. BTTR fell 11.3% to $0.3236 in pre-market trading after gaining over 5% on Tuesday.
- Janover Inc. JNVR fell 8.1% to $1.49 in pre-market after surging 38% on Tuesday.
Now Read This: Campbell Soup, SentinelOne And 3 Stocks To Watch Heading Into Wednesday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.